Search

Your search keyword '"Viganò, Chiara"' showing total 168 results

Search Constraints

Start Over You searched for: Author "Viganò, Chiara" Remove constraint Author: "Viganò, Chiara"
168 results on '"Viganò, Chiara"'

Search Results

2. SARS-CoV-2 infection in patients with inflammatory bowel disease: comparison between the first and second pandemic waves

3. Switching from VEDOlizumab intravenous to subcutaneous formulation in ulcerative colitis patients in clinical remission: The SVEDO Study, an IG-IBD study

6. Reduced humoral response to two doses of COVID-19 vaccine in patients with inflammatory bowel disease: Data from ESCAPE-IBD, an IG-IBD study

9. Endoscopic Findings in Patients Infected With 2019 Novel Coronavirus in Lombardy, Italy

12. Prevalence of Disease-Related Malnutrition and Micronutrients Deficit in Patients with Inflammatory Bowel Disease: A Multicentric Cross-Sectional Study by the GSMII (Inflammatory Bowel Disease Study Group).

15. Lack of Seroconversion Following COVID-19 Vaccination Is an Independent Risk Factor for SARS-CoV-2 Infection in Patients With Inflammatory Bowel Disease: Data from ESCAPE-IBD, an IG-IBD Study.

16. Prevalence of Disease-Related Malnutrition and Micronutrients Deficit in Patients with Inflammatory Bowel Disease: A Multicentric Cross-Sectional Study by the GSMII (Inflammatory Bowel Disease Study Group)

17. Switching from VEDOlizumab intravenous to subcutaneous formulation in ulcerative colitis patients in clinical remission: The SVEDO Study, an IG-IBD study

18. Early and delayed complications of polypectomy in a community setting: The SPoC prospective multicentre trial

19. 12 COMPARISON OF TWO STRATEGIES FOR THE MANAGEMENT OF POSTOPERATIVE RECURRENCE IN CROHN'S DISEASE PATIENTS WITH ONE CLINICAL RISK FACTOR: A MULTICENTRE ITALIAN STUDY

20. Comparison of two strategies for the management of postoperative recurrence in Crohn’s disease patients with one clinical risk factor: A multicentre IG‐IBD study

22. Reduced humoral response to two doses of COVID-19 vaccine in patients with inflammatory bowel disease: Data from ESCAPE-IBD, an IG-IBD study

25. Safety, hesitancy of coronavirus disease 2019 vaccination and pandemic burden in patients with inflammatory bowel disease: data of a national study (ESCAPE-IBD).

27. Endoscopic Postoperative Recurrence in Crohn’s Disease After Curative Ileocecal Resection with Early Prophylaxis by Anti-TNF, Vedolizumab or Ustekinumab: A Real-World Multicentre European Study

30. Tu1819 REAL-LIFE EFFECTIVENESS AND SAFETY OF TOFACITINIB AND VEDOLIZUMAB AS A SECOND-LINE THERAPY IN ANTI-TNFS EXPERIENCED PATIENTS ULCERATIVE COLITIS: PRELIMINARY RESULTS OF AN IGIBD STUDY (VE2TO-UC)

31. Mo1814 PREVALENCE, ETIOLOGY AND OUTCOME OF ACUTE PANCREATITIS IN INFLAMMATORY BOWEL DISEASE: EUROPEAN PANDORA STUDY

33. Impact of Structural Changes on Multifocal Electroretinography in Patients With Use of Hydroxychloroquine

36. Real-Life Management of Central and Branch Retinal Vein Occlusion: A Seven-Year Follow-Up Study

40. Outcomes of COVID-19 in 79 patients with IBD in Italy: an IG-IBD study

42. Therapies for inflammatory bowel disease do not pose additional risks for adverse outcomes of SARS‐CoV‐2 infection: an IG‐IBD study.

43. Supplemental material for Terminal ileum ileoscopy and histology in patients undergoing high-definition colonoscopy with virtual chromoendoscopy for chronic nonbloody diarrhea: A prospective, multicenter study

44. Terminal ileum ileoscopy and histology in patients undergoing high‐definition colonoscopy with virtual chromoendoscopy for chronic nonbloody diarrhea: A prospective, multicenter study

45. Genotypic and phenotypic factors influencing the rate of progression in ABCA-4-related Stargardt disease.

48. Letter: Mendelian randomization ‐ new perspective in inflammatory bowel disease and pancreatic cancer? Authors' reply.

Catalog

Books, media, physical & digital resources